HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A pertussis outbreak among daycare children in Northern Israel: who gets sick?

AbstractBACKGROUND:
An outbreak of pertussis occurred in a daycare center with 87.5% vaccination coverage.
OBJECTIVES:
To assess the effectiveness of the acellular pertussis vaccine and prevention of pertussis after chemoprophylaxis with azithromycin.
METHODS:
We studied 31 daycare children aged 3-5.5 years exposed to a child with pertussis. Nasopharyngeal swabs were obtained for Bordetella pertussis culture and polymerase chain reaction initially, and at days 21 and 60 of follow-up, in cases exhibiting symptoms.
RESULTS:
Of the 31 daycare children 6 (19%) tested positive for 8. pertussis by PCR, 4 of whom had not been vaccinated against the disease. Of the two vaccinated children who contracted pertussis, one had milder symptoms and the other was asymptomatic. The incidence of pertussis was significantly lower in the vaccinated group (2/27) than in the unvaccinated group (4/4) (P = 0.000), with efficacy of the vaccine calculated to be 92.5%. Azithromycin chemoprophylaxis was taken only by 14 of the 25 exposed children (56%). On day 21 follow-up, there was no further laboratory-diagnosed B. pertussis cases in any of the exposed children, regardless of whether or not chemoprophylaxis was taken.
CONCLUSIONS:
Based o the children's clinical manifestations and PCR findings a pertussis outbreak had occurred in the daycare center studied. Our findings support the importance of pertussis vaccination since all the unvaccinated children in the daycare center contracted the infection.
AuthorsOri Hochwald, Ellen S Bamberger, Lisa Rubin, Rosa Gershtein, Isaac Srugo
JournalThe Israel Medical Association journal : IMAJ (Isr Med Assoc J) Vol. 12 Issue 5 Pg. 283-6 (May 2010) ISSN: 1565-1088 [Print] Israel
PMID20929081 (Publication Type: Journal Article)
Chemical References
  • Anti-Bacterial Agents
  • Pertussis Vaccine
  • Azithromycin
Topics
  • Anti-Bacterial Agents (therapeutic use)
  • Azithromycin (therapeutic use)
  • Chemoprevention
  • Child Day Care Centers (statistics & numerical data)
  • Child, Preschool
  • Disease Outbreaks (prevention & control, statistics & numerical data)
  • Follow-Up Studies
  • Humans
  • Israel (epidemiology)
  • Pertussis Vaccine (therapeutic use)
  • Polymerase Chain Reaction
  • Treatment Outcome
  • Whooping Cough (epidemiology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: